FdaApplication

ANDA 215184

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRUBICON RESEARCH LTD
application_typeANDA
approval_date2021-08-20

Products (3)

ProductActive ingredientStrengthDosage form
METOLAZONEMETOLAZONE2.5MGTABLET;ORAL
METOLAZONEMETOLAZONE5MGTABLET;ORAL
METOLAZONEMETOLAZONE10MGTABLET;ORAL

3 products